Cargando…
Targeting Rac and Cdc42 GEFs in Metastatic Cancer
The Rho family GTPases Rho, Rac, and Cdc42 have emerged as key players in cancer metastasis, due to their essential roles in regulating cell division and actin cytoskeletal rearrangements; and thus, cell growth, migration/invasion, polarity, and adhesion. This review will focus on the close homologs...
Autores principales: | Maldonado, Maria del Mar, Medina, Julia Isabel, Velazquez, Luis, Dharmawardhane, Suranganie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156542/ https://www.ncbi.nlm.nih.gov/pubmed/32322580 http://dx.doi.org/10.3389/fcell.2020.00201 |
Ejemplares similares
-
Rac-GEF/Rac Signaling and Metastatic Dissemination in Lung Cancer
por: Cooke, Mariana, et al.
Publicado: (2020) -
Characterization of Novel Derivatives of MBQ-167, an Inhibitor of the GTP-binding Proteins Rac/Cdc42
por: Medina, Julia I., et al.
Publicado: (2022) -
Pharmacokinetics of the Rac/Cdc42 Inhibitor MBQ-167
in Mice by Supercritical Fluid Chromatography–Tandem Mass Spectrometry
por: Maldonado, María del Mar, et al.
Publicado: (2019) -
Rac inhibition as a novel therapeutic strategy for EGFR/HER2 targeted therapy resistant breast cancer
por: Borrero-García, Luis D., et al.
Publicado: (2021) -
Rac and Cdc42 inhibitors reduce macrophage function in breast cancer preclinical models
por: Torres-Sanchez, Anamaris, et al.
Publicado: (2023)